Annexon (ANNX) Total Liabilities (2019 - 2026)
Annexon's (ANNX) quarterly Total Liabilities came in at $58.4 million in Q1 2026, down 1.49% year-on-year from $59.2 million in Q1 2025, and down 11.48% quarter-over-quarter from $65.9 million in Q4 2025.
Annexon (ANNX) Total Liabilities (2019 - 2026) Analysis & Trends
Annexon's Total Liabilities history runs 8 years deep, the most recent figure standing at $58.4 million for Q1 2026.
- On a quarterly basis, Total Liabilities fell 1.49% year-over-year to $58.4 million in Q1 2026; TTM through Mar 2026 was $58.4 million, a 1.49% decrease from a year earlier, with the FY2025 full-year figure at $65.9 million, up 15.72% from the prior year.
- Total Liabilities fell to $58.4 million in Q1 2026 per ANNX's latest filing, from $65.9 million in the prior quarter.
- Across five years, Total Liabilities topped out at $67.7 million in Q3 2025 and bottomed at $41.7 million in Q1 2024.
- The 5-year median for Total Liabilities is $52.7 million (2022), against an average of $53.7 million.
- Across the five-year window, Total Liabilities surged 329.13% in 2022 and retreated 22.73% in 2024, its largest moves.
- Year by year, Total Liabilities stood at $53.9 million in 2022, then dropped by 12.59% to $47.1 million in 2023, then rose by 20.9% to $57.0 million in 2024, then rose by 15.72% to $65.9 million in 2025, then dropped by 11.48% to $58.4 million in 2026.
- Per Business Quant, the three latest ANNX Total Liabilities figures stand at $58.4 million (Q1 2026), $65.9 million (Q4 2025), and $67.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | 58.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.36 Mn |
| Dec 31, 2025 | 65.92 Mn |
| Sep 30, 2025 | 67.70 Mn |
| Jun 30, 2025 | 65.56 Mn |
| Mar 31, 2025 | 59.24 Mn |
| Dec 31, 2024 | 56.97 Mn |
| Sep 30, 2024 | 47.22 Mn |
| Jun 30, 2024 | 45.01 Mn |
| Mar 31, 2024 | 41.66 Mn |
| Dec 31, 2023 | 47.12 Mn |
| Sep 30, 2023 | 46.98 Mn |
| Jun 30, 2023 | 48.29 Mn |
| Mar 31, 2023 | 53.92 Mn |
| Dec 31, 2022 | 53.90 Mn |
| Sep 30, 2022 | 52.12 Mn |
| Jun 30, 2022 | 52.66 Mn |
| Mar 31, 2022 | 49.96 Mn |
| Dec 31, 2021 | 55.13 Mn |
| Sep 30, 2021 | 45.68 Mn |
| Jun 30, 2021 | 36.45 Mn |